Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CRMD
$7.27
+1.11%
CRMD
· CorMedix Inc.
$7.27
+0.08 (+1.11%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$611.47M
Shares
77.94M
Volume · Oct 5
768.55K
Avg daily vol (3M)
1.06M
All webcasts
Earnings call · FY2026 Q2
CorMedix Inc. (CRMD) Q2 2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$101.93M
+156.5% YoY
Diluted EPS
$0.29
+3.6% YoY
Gross margin
75.7%
-19.6 pp YoY
Net income
$25.99M
+31.1% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 13, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Consolidated revenue
Initiated
full-year 2026
|
$325M – $345M | — | |
|
Adjusted EBITDA
Initiated
full-year 2026
|
$125M – $140M | Non-GAAP | |
|
Cash OpEx
Initiated
full-year 2026
|
$145M – $155M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document